The scientific opinion of the SCCS of the cosmetic ingredient Citral on the sensitization endpoint is requested. Citral (CAS No. 5392-40-5, EC No. 226-394-6) with the chemical name ‘3,7-Dimethyl-2,6- octadienal’ is a mixture of neral and geranial, which are...
Legal Cosmetic Area
Nanomaterials – Europe notifies the WTO of the update of Regulation 1223/2009
On February 11, 2022, the European Commission notified the WTO of the draft Commission Regulation amending Regulation (EC) No 1223/2009 with regard to the use of nanomaterials. This draft measure is necessary to enact a ban on the use in cosmetic products of certain...
Working Group meeting on Nanomaterials
On February 4, the SCCS Nanomaterials Working Group met to address issues that are currently in process. The following draft opinions were discussed at the Working Group meeting: Fullerenes: Letters to Notifiers were finalised and adopted by SCCS Silica: industry has...
Benzoyl peroxide – Consultation for the harmonization of classification and labeling CLP
Ireland has made a proposal for a harmonized classification of the ingredient Benzoyl peroxide. Benzoyl peroxide, INCI name of the substance Dibenzoyl peroxide, with CAS 94-36-0, is used in cosmetics for its function as an oxidant. Currently, it is regulated within...
Working Group meeting on Nanomaterials
On January 20, the SCCS Nanomaterials Working Group met to address issues that are currently in process. The following draft opinions were discussed at the Working Group meeting: Fullerenes New dossiers received on Silica (nano) (Silica, Hydrated Silica, Silica...
Prostaglandins and prostaglandin-analogues – Final Opinion
The SCCS has published its final opinion on the cosmetic ingredient Prostaglandins and their analogs. On September 28, 2021, the preliminary version of the SCCS opinion on the ingredient Prostaglandins and their analogs was published. The conclusions of the SCCS...
Salicylic Acid – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Salicylic acid as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on cosmetic...
Benzyl Salicylate – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Benzyl Salicylate as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on...
Methylparaben – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Methylparaben as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on cosmetic...
Europe notifies the WTO of the update of Regulation (EC) 1223/2009
On February 3, 2022, the European Commission notified the World Trade Organization (WTO) of the presentation of a draft Regulation Project aimed at prohibiting or regulating substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR) by Regulation...
Update of the Appendix for nanoforms published – Nanomaterials
ECHA has published an update to the Appendix for nanoforms applicable to the Guidance on Registration and Substance Identification (v.2.0). The main changes include additional guidance on the joint submission of data, clarifications regarding the need for one dataset...
Authorization List – Information on Proposed Substances
ECHA invites comments on its proposal to include eight substances of very high concern in the REACH authorization list. ECHA regularly assesses the substances on the candidate list to decide which ones should be included in the authorization list (Annex XIV) as a...





